Among them, C32 (CD56+, CD16+, CD57−, CD28−) and C27 (CD56+, CD16+, CD57+, CD28−) increased in PD patients compared to those in HCs, and both increased in patients with LOPD compared to those in EHCs (Fig. 3a, b, f, g). This evidence concerns the gene B3GAT1 and Parkinson disease.